---
title: "BeyondSpring appoints Min Qiu as CEO and Na Li as CFO; Lan Huang to remain as Chair"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288713354.md"
description: "BeyondSpring announced a leadership transition effective July 1, 2026. Min Qiu is appointed CEO and Na Li as CFO. Dr. Lan Huang transitions from CEO to remain Chair, while Dr. Jiangwen Majeti becomes Vice Chair."
datetime: "2026-06-04T11:33:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288713354.md)
  - [en](https://longbridge.com/en/news/288713354.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288713354.md)
generator: "portal-rs"
---

# BeyondSpring appoints Min Qiu as CEO and Na Li as CFO; Lan Huang to remain as Chair

**BeyondSpring appointed Min Qiu as Chief Executive Officer and Na Li as Chief Financial Officer, effective July 1, 2026, while Dr. Lan Huang transitions from CEO to continue as Chair and Dr. Jiangwen Majeti becomes Vice Chair.**

Individual

Dr. Lan Huang

Min Qiu

Na Li

Dr. Jiangwen Majeti

Role

Chair of the Board; outgoing Chief Executive Officer

Chief Executive Officer

Chief Financial Officer

Vice Chair of the Board; Chair of Nominating & Corporate Governance Committee; Compensation Committee member

Type of Change

Transition from CEO to continue as Chair

Appointment

Appointment

Appointment

Effective Date

July 1, 2026

July 1, 2026

July 1, 2026

July 1, 2026

Reason

Company announced leadership transition

Company appointment (no further reason disclosed)

Company appointment (no further reason disclosed)

Board appointment (no further reason disclosed)

Replacement Info

Replaced as CEO by Min Qiu

N/A

N/A

N/A

Background Details

Not disclosed beyond current Chair role

Vice General Manager of Wanchunbulin (subsidiary) Apr 2026; same role Aug 2020–Aug 2023; advisor Sep 2023–Mar 2026; former Board Secretary and healthcare analyst; BPharm; MEng (Univ. of Tokyo)

CFO of Wanchunbulin since Nov 2020; holds Accountant, CFO Qualification, and SSE Board Secretary Qualification Certificates; former Board Secretary roles on Shanghai and Beijing exchanges

Current Chair of Nominating & Corporate Governance Committee and member of Compensation Committee

Board/Committee Role Changes

Will remain Chair of the Board

Not disclosed

Not disclosed

Appointed Vice Chair of the Board

Original SEC Filing: BeyondSpring Inc. \[ BYSI \] - 8-K - Jun. 04, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [BYSI.US](https://longbridge.com/en/quote/BYSI.US.md)

## Related News & Research

- [BeyondSpring Q2 FY26 net loss narrows to $1.8 million; cash falls to $6.5 million](https://longbridge.com/en/news/295977996.md)
- [BeyondSpring posts investor deck highlighting plinabulin late-stage NSCLC program and immune-modulating approach](https://longbridge.com/en/news/296010507.md)
- [Public Storage announces R$ 0.41 per unit dividend for Q3 2026](https://longbridge.com/en/news/296635332.md)
- [Corning sets Q3 2026 dividend at R$ 0.25 per unit](https://longbridge.com/en/news/296635714.md)
- [Northrop Grumman announces R$ 0.17 per unit dividend for Q3 2026](https://longbridge.com/en/news/296645808.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**